These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of calcium channel blockers in reactive airway disease. Townley RG; Cheng J; Bewtra AK; Nair N; Hopp R; Agrawal DK Ann N Y Acad Sci; 1988; 522():732-46. PubMed ID: 3288066 [No Abstract] [Full Text] [Related]
5. [New advances in the clinical uses of calcium antagonists]. Huang SB Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):115-7. PubMed ID: 2670103 [No Abstract] [Full Text] [Related]
6. [Advances in the treatment of pulmonary hypertension with calcium channel blockers]. Yan S; Jia YL Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):379-81. PubMed ID: 3058424 [No Abstract] [Full Text] [Related]
7. Treating coexisting cardiovascular and pulmonary disease with calcium antagonists. Berman BA; Ross RN Ann Allergy; 1986 Mar; 56(3):195-200. PubMed ID: 2420238 [No Abstract] [Full Text] [Related]
8. [Pathogenetic basis of treatment for chronic obstructive pulmonary disease]. Kozak-Szkopek E; Dworzański W; Hanzlik J Pol Merkur Lekarski; 1996 Jul; 1(1):56-9. PubMed ID: 9156898 [TBL] [Abstract][Full Text] [Related]
9. [Foridon in the combined treatment of patients with chronic obstructive lung diseases]. Mikunis RI; Demidiuk VT Vrach Delo; 1990 Apr; (4):68-9. PubMed ID: 2275174 [TBL] [Abstract][Full Text] [Related]
11. New concepts in bronchodilator therapy. Owens GR Am Fam Physician; 1986 Jan; 33(1):218-29. PubMed ID: 2934965 [No Abstract] [Full Text] [Related]
12. [Calcium antagonists and hypertension: a slice of real life]. Guazzi MD Cardiologia; 1996 Mar; 41(3):205-7. PubMed ID: 8697477 [No Abstract] [Full Text] [Related]
13. [Farmacotherapeutisch Kompas 1992]. de Boer JE; Danz M; van Oppenraay ML; Schutte MK; Verduijn JP Ned Tijdschr Geneeskd; 1992 Feb; 136(6):273-6. PubMed ID: 1311057 [No Abstract] [Full Text] [Related]
14. Erythropoietin in chronic obstructive pulmonary disease. Relationship between serum erythropoietin, blood hemoglobin and lung function--effect of the calcium antagonist isradipine on serum erythropoietin. Graudal N; Galløe AM; Nielsen OJ Respiration; 1991; 58(3-4):141-4. PubMed ID: 1836066 [TBL] [Abstract][Full Text] [Related]
15. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. Sajkov D; Wang T; Frith PA; Bune AJ; Alpers JA; McEvoy RD Chest; 1997 Jun; 111(6):1622-30. PubMed ID: 9187185 [TBL] [Abstract][Full Text] [Related]
16. Management of hypertension in patients with obstructive airway disease. George RB Chest; 1985 Sep; 88(3 Suppl):190S-193S. PubMed ID: 2863092 [No Abstract] [Full Text] [Related]
17. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study. Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921 [TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease. Bratel T; Hedenstierna G; Nyquist O; Ripe E Eur J Respir Dis; 1986 May; 68(5):351-61. PubMed ID: 3732430 [TBL] [Abstract][Full Text] [Related]
19. Role of calcium-channel blockers in obstructive airway disease. Ahmed T; Abraham WM Chest; 1985 Aug; 88(2 Suppl):142S-151S. PubMed ID: 2410203 [No Abstract] [Full Text] [Related]
20. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease. Bratel T; Hedenstierna G; Nyquist O; Ripe E Eur J Respir Dis; 1985 Oct; 67(4):244-53. PubMed ID: 4076363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]